ClinConnect ClinConnect Logo
Search / Trial NCT05044520

Clinical Features Associated With Restless Legs Syndrome.

Launched by UNIVERSITY HOSPITAL, MONTPELLIER · Sep 6, 2021

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Restless Legs Syndrome Augmentation Syndrome Dopamine Agonists Alpha 2 Delta Ligands Opiates

ClinConnect Summary

This clinical trial is studying Restless Legs Syndrome (RLS), a condition that causes an uncomfortable urge to move the legs, especially at night when you're trying to relax. This can lead to problems like not getting enough sleep, feeling tired during the day, and having a lower quality of life. The researchers want to learn more about how different factors, like other health conditions and the medications people take for RLS, affect the severity of symptoms over time. They are focusing on a large group of people who are members of RLS associations in France and other European countries.

To be eligible for this study, participants need to be adults who have been diagnosed with RLS, are French-speaking, and can understand the study details. They also need to be members of an RLS association and agree to take part by signing a consent form. The study is currently looking for participants, and those who join can expect to share their experiences with RLS, which will help researchers better understand how to manage this condition in the future. If you or someone you know has RLS, this might be an opportunity to contribute to important research that could improve treatment options.

Gender

ALL

Eligibility criteria

  • Inclusion criteria:
  • Adults subjects
  • Restless legs syndrome diagnosis
  • Member of the restless legs syndrome association
  • French speaking
  • Able to understand the study
  • Signed written informed consent
  • Affiliated to social security
  • Exclusion criteria:
  • - Vulnerable subject : subject deprived of liberty or protected by law (trusteeship, legal guardianship)

About University Hospital, Montpellier

The University Hospital of Montpellier is a leading academic medical institution dedicated to advancing healthcare through innovative research and clinical trials. Renowned for its commitment to patient-centered care, the hospital collaborates with multidisciplinary teams to explore cutting-edge treatments and therapies across various medical fields. By integrating clinical practice with education and research, the University Hospital of Montpellier aims to enhance health outcomes and contribute to the scientific community's understanding of complex medical conditions. Its robust infrastructure and expertise make it a pivotal player in the landscape of clinical research.

Locations

Montpellier, , France

Patients applied

PO

1 patients applied

Trial Officials

Yves DAUVILLIERS, MD PhD

Study Director

University Hospital, Montpellier

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials